Method for treating proliferative disorders associated with protooncogene products

Details for Australian Patent Application No. 2012200157 (hide)

Owner Synta Pharmaceuticals Corp.

Inventors Foley, Kevin; Du, Zhenjian

Agent Davies Collison Cave

Pub. Number AU-A-2012200157

Parent 2007267843

Filing date 11 January 2012

Wipo publication date 9 February 2012

International Classifications

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4152 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4166 (2006.01)

A61K 31/4178 (2006.01)

A61K 31/4188 (2006.01)

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/4439 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/52 (2006.01)

A61K 31/5377 (2006.01)

A61K 31/538 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 February 2012 Complete Application Filed

9 February 2012 Application Open to Public Inspection

  Published as AU-A-2012200157

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012200158-Methods and apparatus for controlling loads coupled to an electrical grid

2012200156-"Treatment of bone disorders with skeletal anabolic drugs"